Ivantis Completes Pre-Market Approval Submission for the Hydrus™ Microstent for Minimally Invasive Glaucoma Surgery (MIGS)

IRVINE, CA–(Marketwired – Oct 31, 2017) – Ivantis Inc., developer of the novel Hydrus™ Microstent, a device designed to lower eye pressure for open-angle glaucoma patients, announced today that it has submitted its final Pre-Market-Approval (PMA) module to the U.S. Food and Drug Administration (FDA) for market approval.

Ivantis Completes Pre-Market Approval Submission for the Hydrus™ Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Read More »

Appier Announces Series C Investment Round with Softbank Group, LINE Corporation, NAVER Corporation, EDBI and AMTD Group

TAIPEI, Taiwan – August 30, 2017 – Appier, a leading artificial intelligence (AI) company, announced that it has secured Series C investment of USD$33 million from SoftBank Group Corp., LINE Corporation, NAVER Corporation, Singaporebased EDBI and Hong Kong-based AMTD Group. This brings the total amount of investment in the company to over USD$82 million.

Appier Announces Series C Investment Round with Softbank Group, LINE Corporation, NAVER Corporation, EDBI and AMTD Group Read More »

Swisslog Healthcare Invests in Savioke’s Mobile Robotics Technology

Denver, CO, Aug. 28, 2017 (GLOBE NEWSWIRE) — Swisslog Healthcare, a leading supplier of solutions for medication and supply chain management in healthcare, announces its investment in Savioke, developer of the Relay autonomous delivery robot, a friendly indoor service robot that works safely, securely and reliably in human environments.

Swisslog Healthcare Invests in Savioke’s Mobile Robotics Technology Read More »